• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Is Pear’s demise a sign of things to come for digital therapeutics?

cafead

Administrator
Staff member
  • cafead   Apr 19, 2023 at 10:22: AM
via As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker times to come.

article source
 

<